HK1079988A1 - 感官可接受的口腔內崩解組合物 - Google Patents

感官可接受的口腔內崩解組合物

Info

Publication number
HK1079988A1
HK1079988A1 HK06100055.6A HK06100055A HK1079988A1 HK 1079988 A1 HK1079988 A1 HK 1079988A1 HK 06100055 A HK06100055 A HK 06100055A HK 1079988 A1 HK1079988 A1 HK 1079988A1
Authority
HK
Hong Kong
Prior art keywords
organoleptically acceptable
disintegrating compositions
intraorally disintegrating
intraorally
compositions
Prior art date
Application number
HK06100055.6A
Other languages
English (en)
Inventor
T．T．勒
B．C．路德維格
J．P．裡奧
U．J．沙
K．山本
Original Assignee
法瑪西雅公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 法瑪西雅公司 filed Critical 法瑪西雅公司
Publication of HK1079988A1 publication Critical patent/HK1079988A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
HK06100055.6A 2001-09-26 2006-01-04 感官可接受的口腔內崩解組合物 HK1079988A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32535601P 2001-09-26 2001-09-26
PCT/US2002/030048 WO2003026697A2 (en) 2001-09-26 2002-09-23 Organoleptically acceptable intraorally disintegrating compositions

Publications (1)

Publication Number Publication Date
HK1079988A1 true HK1079988A1 (zh) 2006-04-21

Family

ID=23267542

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06100055.6A HK1079988A1 (zh) 2001-09-26 2006-01-04 感官可接受的口腔內崩解組合物

Country Status (25)

Country Link
US (1) US20030181501A1 (zh)
EP (2) EP1429736A2 (zh)
JP (2) JP2005512964A (zh)
KR (2) KR20040044990A (zh)
CN (2) CN1703203A (zh)
AP (2) AP2004002999A0 (zh)
AR (1) AR037239A1 (zh)
BR (2) BR0212778A (zh)
CA (2) CA2461044A1 (zh)
CO (2) CO5570659A2 (zh)
EA (2) EA200400352A1 (zh)
EC (1) ECSP045029A (zh)
GE (1) GEP20063856B (zh)
HK (1) HK1079988A1 (zh)
IL (2) IL160848A0 (zh)
IS (2) IS7177A (zh)
MA (2) MA27542A1 (zh)
MX (2) MXPA04002652A (zh)
NO (2) NO20041258L (zh)
OA (2) OA12707A (zh)
PL (2) PL369298A1 (zh)
TN (2) TNSN04045A1 (zh)
WO (2) WO2003026623A1 (zh)
YU (1) YU34804A (zh)
ZA (2) ZA200401953B (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005002557A1 (en) * 2003-07-03 2005-01-13 Warner-Lambert Company Llc Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof
US20050186271A1 (en) * 2004-02-24 2005-08-25 Sheskey Paul J. Process for dispersing a fluid in a mass of solid particles
KR20070040389A (ko) * 2004-08-10 2007-04-16 아지노모토 가부시키가이샤 쓴 맛이 감소된 나테글리니드 함유 제제
JP5209876B2 (ja) * 2004-12-28 2013-06-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 速崩壊性錠剤及びその製造方法
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
TW200732000A (en) * 2005-12-20 2007-09-01 Eisai R&D Man Co Ltd Orally disintegrating table comprising fat-soluble drug
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8865743B2 (en) * 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
US20070196494A1 (en) * 2006-02-17 2007-08-23 Arnaud Grenier Low-friability, patient-friendly orally disintegrating formulations
US20110318412A1 (en) * 2006-05-19 2011-12-29 Somaxon Pharmaceuticals, Inc. Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
US8685457B2 (en) * 2007-06-06 2014-04-01 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
CN101707930B (zh) * 2007-06-06 2013-10-30 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制剂
EP2164460B1 (de) * 2007-06-06 2017-08-09 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
WO2008148734A1 (de) * 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von kau- und lutsch-tabletten
ES2635137T3 (es) * 2007-08-07 2017-10-02 Acelrx Pharmaceuticals, Inc. Formas de dosificación oral transmucosal que comprenden sufentanilo y triazolam
WO2009118589A2 (en) 2008-03-24 2009-10-01 Wockhardt Research Centre Orally disintegrating compositions of rhein or diacerein
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
EP2808013A1 (en) * 2008-11-25 2014-12-03 Mitsubishi Tanabe Pharma Corporation Orally rapidly disintegrating tablet and process for producing same
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
CN106822007B (zh) 2015-09-11 2021-12-31 西姆莱斯股份公司 口服制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
CA2178686A1 (en) * 1995-06-13 1996-12-14 Leslie G. Humber Oral formulations of s(+)-etodolac
JPH11513641A (ja) * 1995-10-20 1999-11-24 ファルマシア・アンド・アップジョン・カンパニー ブリスターパッケージ
IL126899A (en) * 1996-05-17 2004-03-28 Merck & Co Inc Preparations for once-daily treatment of diseases mediated by cyclooxygenase-2
EP0863134A1 (en) * 1997-03-07 1998-09-09 Merck Frosst Canada Inc. 2-(3,5-difluorophenyl)-3-(4-(methyl-sulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cyclooxygenase-2
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
PL351069A1 (en) * 1999-12-08 2003-03-10 Pharmacia Corp Valdecoxib compositions
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
US6800297B2 (en) * 2000-06-15 2004-10-05 Acusphere, Inc. Porous COX-2 inhibitor matrices and methods of manufacture thereof
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
ES2265439T3 (es) * 2000-08-18 2007-02-16 Pharmacia Corporation Formulacion oral de valdecoxib que se desintegra rapidamente.

Also Published As

Publication number Publication date
OA12707A (en) 2006-06-26
KR20040058189A (ko) 2004-07-03
CO5570659A2 (es) 2005-10-31
ZA200402364B (en) 2005-01-13
IS7178A (is) 2004-03-11
YU34804A (sh) 2006-08-17
BR0212778A (pt) 2004-12-07
OA13060A (en) 2006-11-10
MA27682A1 (fr) 2006-01-02
MXPA04002652A (es) 2004-06-07
WO2003026623A1 (en) 2003-04-03
AR037239A1 (es) 2004-11-03
JP2005506987A (ja) 2005-03-10
EA200400352A1 (ru) 2004-12-30
CN1703203A (zh) 2005-11-30
ZA200401953B (en) 2005-05-09
TNSN04047A1 (fr) 2006-06-01
PL369298A1 (en) 2005-04-18
CA2461630A1 (en) 2003-04-03
ECSP045029A (es) 2004-04-28
MA27542A1 (fr) 2005-10-03
IL160848A0 (en) 2004-08-31
AP2004002998A0 (en) 2004-03-31
TNSN04045A1 (fr) 2006-06-01
EA200400357A1 (ru) 2004-08-26
IS7177A (is) 2004-03-11
CN1633281A (zh) 2005-06-29
WO2003026697A3 (en) 2003-07-03
EP1490035A1 (en) 2004-12-29
IL160855A0 (en) 2004-08-31
EP1429736A2 (en) 2004-06-23
BR0212861A (pt) 2004-10-05
AP2004002999A0 (en) 2004-03-31
WO2003026697A2 (en) 2003-04-03
CA2461044A1 (en) 2003-04-03
WO2003026623A8 (en) 2004-09-30
PL369297A1 (en) 2005-04-18
GEP20063856B (en) 2006-06-26
NO20041258L (no) 2003-03-27
KR20040044990A (ko) 2004-05-31
MXPA04002798A (es) 2004-07-05
US20030181501A1 (en) 2003-09-25
CO5570684A2 (es) 2005-10-31
NO20041532L (no) 2004-04-15
JP2005512964A (ja) 2005-05-12

Similar Documents

Publication Publication Date Title
HK1079988A1 (zh) 感官可接受的口腔內崩解組合物
HUP0600342A3 (en) Glycoprotein compositions
PL365518A1 (en) Oral composition
HUP0400174A2 (en) Lipid-polymer-conjugates compositions
GB0126244D0 (en) Oral compositions
GB0200763D0 (en) Compositions
AU2002365093A8 (en) Therapeutic compositions
GB0105622D0 (en) Compositions
GB0016067D0 (en) Oral compositions
GB0009609D0 (en) Therapeutic compositions
GB0030857D0 (en) Therapeutic compositions
GB0000438D0 (en) Dental compositions
GB0022297D0 (en) Oral compositions
GB0109428D0 (en) Therapeutic compositions
GB0018230D0 (en) Dental compositions
GB0103328D0 (en) Compositions
GB0115893D0 (en) Formulations
GB0108815D0 (en) Dental compositions
GB0125699D0 (en) Dental chisel
GB0008282D0 (en) Dental compositions
GB0018227D0 (en) Dental compositions
EG23003A (en) Synergistic formulations
GB2390303B (en) Oral compositions
AU2002366052A8 (en) Dentifrice compositions
GB0117325D0 (en) Therapeutic compositions